Abstract
Lutein has been used as a dietary supplement for the treatment of eye diseases, especially age-related macular degeneration. For oral formulations, we investigated lutein stability in artificial set-ups mimicking different physiological conditions and found that lutein was degraded over time under acidic conditions. To enhance the stability of lutein upon oral intake, we developed enteric-coated lutein solid dispersions (SD) by applying a polymer, hydroxypropyl methylcellulose acetate succinate (HPMCAS-LF), through a solvent-controlled precipitation method. The SD were characterized in crystallinity, morphology, and drug entrapment. In the dissolution profile of lutein SD, a F80 formulation showed resistance toward the acidic environment under simulated gastric conditions while exhibiting a bursting drug release under simulated intestinal conditions. Our results highlight the potential use of HPMCAS-LF as an effective matrix to enhance lutein bioavailability during oral delivery and to provide novel insights into the eye-care supplement industry, with direct benefits for the health of patients. Graphical abstract: [Figure not available: see fulltext.].
| Original language | English |
|---|---|
| Article number | 169 |
| Journal | AAPS PharmSciTech |
| Volume | 22 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jul 2021 |
Keywords
- absorption
- bioavailability
- degradation
- lutein
- oral drug delivery
- pH sensitivity
- solid dispersion
- stability